Metformin Compounding Legal Status: What Patients and Prescribers Need to Know
A complete guide to metformin's FDA approval history, compounding legal status, label requirements, and post-market safety record. Reviewed by the HealthRX medical team.
Metformin: Regulatory History
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
8articles
4topic areas covered
Jan 28, 2025latest review
Metformin: Regulatory History library
Showing 8 of 8 clinical reviews.
Metformin EMA vs FDA Approach: How Two Regulators Govern the World's Most Prescribed Diabetes Drug
A side-by-side comparison of how the FDA and EMA regulate metformin, including approval history, label differences, renal thresholds, safety monitoring, and post-market surveillance.
Metformin FAERS Safety Signals: Post-Market Surveillance Data and FDA Reporting Trends
A clinical review of metformin safety signals in the FDA Adverse Event Reporting System (FAERS), including lactic acidosis, B12 deficiency, NDMA contamination, and updated renal dosing guidance.
Metformin FDA Approval History: From European Staple to America's Most Prescribed Diabetes Drug
A complete timeline of metformin's FDA approval, label expansions, safety reviews, and regulatory milestones from 1994 to the present day.
Metformin Global Regulatory Status: FDA Approval, International Labels, and Post-Market Safety
A complete overview of metformin's regulatory history across the FDA, EMA, and other global agencies, including approval timelines, labeling updates, NDMA concerns, and current prescribing status.
Metformin Label Updates 2020-2026: FDA Safety Changes, Renal Thresholds, and NDMA Recalls
A complete timeline of metformin FDA label changes from 2020 through 2026, including the eGFR renal threshold expansion, NDMA impurity recalls, vitamin B12 monitoring, and updated lactic acidosis language.
Metformin Legal & Patent Challenges: FDA Approval, Label History, and Safety Oversight
A complete guide to metformin's regulatory history, patent expiration, FDA label updates, NDMA contamination actions, and ongoing post-market safety surveillance, reviewed by the HealthRX medical team.
Metformin Pipeline, FDA Regulatory History, and Next-Generation Formulations
A comprehensive look at metformin's FDA approval history, current label requirements, post-market surveillance findings, and what next-generation biguanide-class research means for clinical practice.